CalciMedica, Inc.
CALC
$0.72
-$0.10-12.49%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.91% | 0.31% | 6.60% | -0.15% | 2.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.47% | 11.44% | 16.68% | 15.96% | 10.65% |
| Operating Income | 4.47% | -11.44% | -16.68% | -15.96% | -10.65% |
| Income Before Tax | -115.78% | -69.71% | -65.81% | -26.33% | 60.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -115.78% | -69.71% | -65.81% | -26.33% | 60.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -115.78% | -69.71% | -65.81% | -26.33% | 60.12% |
| EBIT | 4.47% | -11.44% | -16.68% | -15.96% | -10.65% |
| EBITDA | 4.44% | -11.51% | -16.74% | -16.02% | -10.68% |
| EPS Basic | -66.04% | -2.00% | 15.55% | 41.41% | 95.50% |
| Normalized Basic EPS | -66.04% | -2.00% | 15.55% | 41.41% | 81.65% |
| EPS Diluted | -65.83% | -1.98% | 15.54% | 41.37% | 95.48% |
| Normalized Diluted EPS | -66.00% | -1.98% | 15.57% | 41.41% | 81.64% |
| Average Basic Shares Outstanding | 33.47% | 51.37% | 64.79% | 83.97% | 151.39% |
| Average Diluted Shares Outstanding | 32.61% | 50.20% | 63.31% | 81.98% | 153.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |